Home > Research > Publications & Outputs > Anti-interleukin-13 and anti-interleukin-4 agen...

Research

Electronic data

  • Edwards_et_al-2018-

    Rights statement: This is the Published version of the following article: Edwards M, Gallagher A, Nair P, Drew S, Vyas A, Sharma R, Marsden PA, Evans DJW. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012929. DOI: 10.1002/14651858.CD012929 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

    Final published version, 208 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. / Edwards, Michaela Jane; Gallagher, A.; Nair, Parameswaran et al.
In: Cochrane Database of Systematic Reviews, No. 1, 22.01.2018.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Edwards, MJ, Gallagher, A, Nair, P, Drew, S, Vyas, A, Sharma, R, Marsden, P & Evans, DJW 2018, 'Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma', Cochrane Database of Systematic Reviews, no. 1. https://doi.org/10.1002/14651858.CD012929

APA

Edwards, M. J., Gallagher, A., Nair, P., Drew, S., Vyas, A., Sharma, R., Marsden, P., & Evans, D. J. W. (2018). Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews, (1). https://doi.org/10.1002/14651858.CD012929

Vancouver

Edwards MJ, Gallagher A, Nair P, Drew S, Vyas A, Sharma R et al. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews. 2018 Jan 22;(1). doi: 10.1002/14651858.CD012929

Author

Edwards, Michaela Jane ; Gallagher, A. ; Nair, Parameswaran et al. / Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. In: Cochrane Database of Systematic Reviews. 2018 ; No. 1.

Bibtex

@article{f718c61f50b04ace9e7c9296440a5054,
title = "Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma",
abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy and safety of anti-interleukin-13 or anti-interleukin-4 agents, compared with placebo, anti-Immunoglobulin E agents, or anti-interleukin-5 agents, for the treatment of children, adolescents, or adults with asthma.",
author = "Edwards, {Michaela Jane} and A. Gallagher and Parameswaran Nair and Stewart Drew and Aashish Vyas and R Sharma and Paul Marsden and Evans, {David John William}",
note = "This is the Published version of the following article: Edwards M, Gallagher A, Nair P, Drew S, Vyas A, Sharma R, Marsden PA, Evans DJW. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012929. DOI: 10.1002/14651858.CD012929 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.",
year = "2018",
month = jan,
day = "22",
doi = "10.1002/14651858.CD012929",
language = "English",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

RIS

TY - JOUR

T1 - Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma

AU - Edwards, Michaela Jane

AU - Gallagher, A.

AU - Nair, Parameswaran

AU - Drew, Stewart

AU - Vyas, Aashish

AU - Sharma, R

AU - Marsden, Paul

AU - Evans, David John William

N1 - This is the Published version of the following article: Edwards M, Gallagher A, Nair P, Drew S, Vyas A, Sharma R, Marsden PA, Evans DJW. Anti-interleukin-13 and anti-interleukin-4 agents versus placebo, anti-interleukin-5 or anti-immunoglobulin-E agents, for children and adults with asthma. Cochrane Database of Systematic Reviews 2018, Issue 1. Art. No.: CD012929. DOI: 10.1002/14651858.CD012929 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

PY - 2018/1/22

Y1 - 2018/1/22

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy and safety of anti-interleukin-13 or anti-interleukin-4 agents, compared with placebo, anti-Immunoglobulin E agents, or anti-interleukin-5 agents, for the treatment of children, adolescents, or adults with asthma.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy and safety of anti-interleukin-13 or anti-interleukin-4 agents, compared with placebo, anti-Immunoglobulin E agents, or anti-interleukin-5 agents, for the treatment of children, adolescents, or adults with asthma.

U2 - 10.1002/14651858.CD012929

DO - 10.1002/14651858.CD012929

M3 - Journal article

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 1

ER -